$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Abstract AI-Helper 아이콘AI-Helper

Ebola virus disease is a lethal viral hemorrhagic fever that has been boiling in sub-Saharan Africa since 1970s. Last year, The Ebola virus epidemic that has spread not only mainly in West Africa, but also in locals such as USA, Europe and the Antipodes via infected travelers, was brought up. Human-...

주제어

참고문헌 (42)

  1. Centers for Disease Control and Prevention (CDC). CDC Public health image library ID# 10816[Internet]. Atlanta, USA: Centers for Disease Control and Prevention (CDC); [cited 2015 Oct 8]. Available from: http://phil.cdc.gov/phil/details.asp?pid10816 

  2. Samaranayake L, Scully C, Nair RG, Petti S. Viral Hemorrhagic fevers with emphasis on Ebola virus disease and oro-dental healthcare. Oral Dis 2015;21:1-6. 

  3. WHO Ebola Response Team. Ebola virus disease in West Africa - the first 9 months of the epidemic and forward projections. N Engl J Med 2014;371(16):1481-1495. 

  4. Casillas AM, Nyamathi AM, Sosa A, Wilder CL, Sands HA. Current review of Ebola virus: pathogenesis, clinical presentation, and diagnostic assessment. Biol Res Nurs 2003;4(4):268-275. 

  5. Centers for Disease Control and Prevention (CDC). Cases of Ebola virus disease in Africa, 1976-2015[Internet]. Atlanta, USA: Centers for Disease Control and Prevention (CDC); 2015 Oct [Cited 2015 Oct 8]. Available from: http://www.cdc.gov/vhf/ebola/outbreaks/history/distribution-map.html. 

  6. Centers for Disease Control and Prevention (CDC). Ebola distribution map[Internet]. Atlanta, USA: Centers for Disease Control and Prevention (CDC); 2015 Oct [Cited 2015 Oct 8]. Available from: http://www.cdc.gov/vhf/ebola/outbreaks/history/distribution- map.html. 

  7. Kawaoka Y. How Ebola virus infects cells. N Engl J Med 2015;352(25):2645-2646. 

  8. Bray M, Geisbert TW. Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. Int J Biochem Cell Biol 2005;37:1560-1566. 

  9. Mahanty S, Bray M. Pathogenesis of Filoviral haemorrhagic fevers. Lancet 2004;4(8):487-488. 

  10. Dowell SF, Mukunu R, Ksiazek TG, Khan AS, Rollin PE, Peters CJ. Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 1999;179(Suppl 1):S87-91. 

  11. Jaax N, Jahrling P, Geisbert T, Geisbert J, Steele K, McKee K, Nagley D, Johnson E, Jaax G, Peters C. Transmission of Ebola virus(Zaire strain) to uninfected control monkeys in a biocontainment laboratory. Lancet 1995;346:1669-1671. 

  12. Johnson E, Jaax N, White J, Jahrling P. Lethal experimental infections of Rhesus monkeys by aerosolized Ebola virus. Int J Exp Pathol 1995;78:227-236. 

  13. Formenty P, Leroy EM, Epelboin A, Libama F, Lenzi M, Sudeck H, Yaba P, Allarangar Y, Boumandouki P, Nkounkou VB, Drosten C, Grolla A, Feldmann H, Roth C. Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. Clin Infec Dis 2006;42:1521-1526. 

  14. Hwang ES. Preparedness for prevention of Ebola virus disease. J Korean Med Sci 2014;29:1185. 

  15. Marzi A, Feldmann H. Ebola virus vaccines: an overview of current approaches. Expert Rev Vaccines 2014;13(4):521-531. 

  16. Martinez MJ, Volchkova VA, Raoul H, Alazard-Dany N, Reynard O, Volchkov VE. Role of VP30 phosphorylation in the Ebola virus replication cycle. J Infect Dis 2011;204(Suppl 3):S934-940. 

  17. Marzi A, Halfmann P, Hill-Batorski L, Feldmann F, Shupert WL, Neumann G, Feldmann H, Kawaoka Y. an Ebola whole-virus vaccine is protective in nonhuman primates. Science 2015;348(6233):439-442. 

  18. Martinez MJ, Salim AM, Hurtado JC, Kilgore PE. Ebola virus infection: overview and update on prevention and treatment. Infect Dis Ther 2015:1-26. 

  19. World Health Organization (WHO). Interim infection prevention and control guidance for care of patients with suspected or confirmed Filovirus haemorrhagic fever in health-care settings with focus on Ebola. Geneva: WHO 2014. 

  20. Centers for Disease Control and Prevention (CDC). Think Ebola: early recognition is critical for infection control[Internet]. Atlanta, USA: Centers for Disease Control and Prevention (CDC); 2015 Sept [Cited 2015 Oct 8]. Available from: http://www.cdc.gov/vhf/ebola/healthcareus/evaluating-patients/think-ebola.html 

  21. Centers for Disease Control and Prevention (CDC). Infection prevention and control recommendations for hospitalized patients under investigation(PUIs) for Ebola Virus Disease(EVD) in U.S. hospitals[Internet]. Atlanta, USA: Centers for Disease Control and Prevention (CDC); 2015 Sept [Cited 2015 Oct 8]. Avaliable from: http://www.cdc.gov/vhf/ebola/healthcareus/hospitals/infection-control.html 

  22. Centers for Disease Control and Prevention (CDC). CDC tightened guidance for U.S. healthcare workers on personal protective equipment for Ebola[Internet]. Atlanta, USA: Centers for Disease Control and Prevention (CDC); 2014 Oct [Cited 2015 Oct 8]. Available from: http://www.cdc.gov/media/releases/2014/fs1020-ebola-personalprotective-equipment.html 

  23. American Dental Association (ADA). Oral Health Topics - Ebola Resources[Internet]. Chicago, USA: American Dental Association (ADA); 2014 Oct [Cited 2015 Oct 8]. Available from: http://www.ada.org/en/member-center/oral-healthtopics/ebola-resources 

  24. Dallatomasina S, Crestani R, Squire JS, Declerk H, Caleo GM, Wolz A, Stinson K, Patten G, Brechard R, Gbabai OB, Spreicher A, Herp MV, Zachariah R. Ebola outbreak in rural West Afica: epidemiology, clinical features and outcomes. Trop Med Int Health 2015;10(4):448-454. 

  25. Bwaka MA, Bonnet MJ, Calain P, Colebunders R, Roo AD, Guimard Y, Katwiki KR, Kibadi K, Kipasa MA, Kuvula KJ, Mapanda BB, Massamba M, Mupapa KD, Muyembe-Tamfum JJ, Ndaberey E, Peters CJ, Rollin PE, Enden EV. Ebola hemorrhagic fever in Kikwit Democratic Republic of the Congo: Clinical observations in 104 patients. J Infect Dis 1999;179(Suppl 1):S1-7. 

  26. Kortepeter MG, Bausch DG, Bray M. Basic clinical and laboratory features of Filoviral hemorrhagic fever. J Infect Dis 2011;204:S810-816. 

  27. Qin E, Bi J, Zhao M, wang Y, Guo T, Yan T, Li Z, Sun J, Zhang J, Chen S, Wu Y, Li J, Zhong Y. Clinical features of patients with Ebola virus disease in Sierra Leone. Clin Infect Dis 2015;61(4):481-485. 

  28. Yan Ti, Mu J, Qin E, Wang Y, Liu L, Wu D, Jia H, Li Z, Guo T, Wang X, Qin Y, Li Y, Chen S, Zhang Y, Zhang J, Wu Y, Wang S, Li J. Clinical characteristics of 154 patients suspected of having Ebola virus disease in the Ebola holding center of Jui government hospital in Sierra Leone during the 2014 Ebola outbreak. Eur J Clin Microbiol Infect Dis 2015;34:2089-2095. 

  29. Bah EI, Lamah MC, Fletcher T, Jacob ST, Brett-Major DM, Sall AA, Shindo N, Fischer ll WA, Lamontagne F, Saliou SM, Bausch DG, Moumie B, Jagatic T, Sprecher A, Lawler JV, Mayet T, Jacquerioz FA, Baggi MFM, Ballenas C, Clement C, Mardel S, Faye O, Faye O, Soropoqui B, Magassouba N, Koivoqui L, Pinto R, Fowler RA. Clinical presentation of patients with Ebola virus disease in Conarky, Guinea. N Engl J Med 2015;372:40-47. 

  30. Bonnet MJ, Akamituna P, Mazaya A. Unrecognized Ebola hemorrhagic fever at Mosango hospital during the 1995 epidemic in Kikwit, Democratic Republic of the Congo. Emerg Infect Dis 1998;4(3):508-510. 

  31. Chertow DS, Kleine C, Edwards JK, Scaini R, Giuliani R, Sprecher A. Ebola virus disease in West Africa - clinical manifestations and management. N Engl J Med 2014;371(22):2054-2057. 

  32. Piot P, Bureau P, Breman G, Heymann D, Kintoki V, Masamba M, Mbuyi M, Miatudila M, Ruppol F, Van Nieuwenhove S, white MK, Vandergroen G, Wulff H, Johnson KM. Clinical aspects of Ebola virus infection in Yambuku area, Zaire, 1976. In: Pattyn SR, ed. Ebola virus haemorrhagic fever. Amsterdam: Elsevier/Morth-Holland Biomedical Press 1978:7-14. 

  33. Isaacson M, Sureau P, Courteille G, Pattyn SR. Clinical aspects of Ebola virus disease at the Ngaliema hospital, Kinshasa, Zaire, 1976. In: Pattyn SR, ed. Ebola virus haemorrhagic fever. Amsterdam: Elsevier/Morth-Holland Biomedical Press 1978:22-26. 

  34. Smith DH, Francis DP, Simpson DIH. African haemorrhagic fever in the Southern Sudan, 1976: clinical manifestations. In: Pattyn SR, ed. Ebola virus haemorrhagic fever. Amsterdam: Elsevier/Morth-Holland Biomedical Press 1978:27-30. 

  35. Sureau PH. Firsthand clinical observations of hemorrhagic manifestations in Ebola hemorrhagic fever in Zaire. Rev Infect Dis 1989;11(4):790-793. 

  36. Hujoel PP, Stott-Miller M. Retinal and gingival hemorrhaging and chronic hyperglycemia. Diabetes Care 2011;34(1):181-184. 

  37. Martin P, Laupland KB, Frost EH, Valiquette L. Laboratory diagnosis of Ebola virus disease. Intensive Care Med 2015;41(5):895-898. 

  38. Shaw M, Palese P. Fields virology. Philadelphia, PA: Lippincott williams & Wilkins 2013:1151-1185. 

  39. Rowe AK, Bertoli J, Khan AS, Mukunu R, Muyembe-Tamfum JJ, Bressler D, Williams AJ, Peters CJ, Rodriguez L, Feldmann H, Nichol ST, Rollin PE, Ksiazek TG. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. J Infect Dis 1999;179(Suppl 1):S28-35. 

  40. Leroy EM, Baize S, Lu CY, McCornick JB, Georges AJ, Georges-Courbot M-C, Lansoud-Soukate J, Fisher-Hoch SP. Diagnosis of Ebola haemorrhagic fever by RT-PCR in an epidemic setting. J Med Virol 2000;60(4):463-467. 

  41. Schieffelin JS, Shaffer JG, Goba A, Gbakie M, Gire SK, Colubri A, Sealfon RSG, Kanneh L, Moigboi A, Momoh M, Fullah M, Moses LM, Brown BL, Andersen KG, Winnicki S, Schffner SF, Park DJ, Yozwiak NL, Jiang PP, Kargbo D, Jalloh S, Fonnie M, Sinnah V, French I, Kovoma A, Kamara FK, Tucker V, Konuwa E, Sellu J, Mustapha I, Foday M, Yillah M, Kanneh F, Saffa S, Masssally JLV, Boisen ML, Branco LM, Vandi MA, Grant DS, Happi B, Gevao SM, Fletcher TE, Fowler RA, Bauch DG, Sabeti PC, Khan SH, Garry RF. Clinical illness and outcomes in patients with Ebola in Sierra Leone. N Engl J Med 2014;371:2092-2100. 

  42. Galvin S, Flint SR, Healy CM. Ebola virus disease: review and implications for dentistry in Ireland. J Ir Dent Assoc 2015;61(3):141-143. 

저자의 다른 논문 :

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로